Celltex has received approval from FDA to proceed with the Company’s Investigational New Drug application (IND 22055) to investigate the Prophylactic Efficacy of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells Against COVID-19.
Pharma companies with drugs in clinical development can now easily, cost effectively and legally reach ALL qualifying clinical trial patients across the United States with RxE2's and Thrifty White Pharmacy's new E2 Dispensing service.
The CEOs of Gerresheimer, Stevanato Group, and SCHOTT are committed to ensuring ample supply of pharmaceutical containers for any COVID-19 vaccine and treatment that is developed, and that no patient shall be left behind, no matter what region of the world they live in.
Rocky Mountain Biologicals, LLC (RMBIO) is now mass producing an essential component of COVID-19 testing kits: Viral Transport Medium (VTM).
QPS, a global contract research organization (CRO) that provides discovery, preclinical, and clinical drug development services, is reinforcing its focus on qualitative and quantitative bioanalysis of biotherapeutics.
Hologic, Inc. (Nasdaq: HOLX) announced today that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its Aptima SARS-CoV-2 assay to detect the novel coronavirus.
As part of a complex plan aimed at restarting the economy, Northwell Health is working with public health officials to provide antibody testing to first-responders across Long Island and..
In response to the COVID-19 pandemic, Gladstone scientists have rapidly pivoted the focus of their research labs to the novel virus, SARS-CoV-2. Specifically, they are leveraging their established tools, unique infrastructure, and diverse expertise in virology to develop improved diagnostics, identify targeted treatment strategies, and..
UK diagnostics firm Intelligent Fingerprinting – developers of the world’s only portable fingerprint-based drug screening system – believes that the highly sensitive fluorescence measurement capabilities of its lateral flow technology...
Sepsis is a life-threatening illness caused by the human body’s immune response to infection, however if the body overreacts it can lead to death. Nearly 270,000 deaths occur in the United States annually related to sepsis.